603108 润达医疗
2023/09 - 九个月2022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)7.11311.36511.40811.07011.760
总资产报酬率 ROA (%)1.9493.1493.4273.4363.734
投入资产回报率 ROIC (%)2.5144.0574.3154.2575.254

边际利润分析
销售毛利率 (%)25.84127.99026.99827.04327.161
营业利润率 (%)7.9147.7798.7799.1079.598
息税前利润/营业总收入 (%)11.54010.89412.10012.41212.999
净利润/营业总收入 (%)6.0046.2426.7527.1277.248

收益指标分析
经营活动净收益/利润总额(%)69.750103.84189.67385.80693.358
价值变动净收益/利润总额(%)34.30816.72017.66621.43117.492
营业外收支净额/利润总额(%)1.6830.4000.341-1.2471.291

偿债能力分析
流动比率 (X)1.2851.1541.2041.1231.081
速动比率 (X)1.0860.9640.9610.9150.855
资产负债率 (%)63.87865.49463.45059.90561.071
带息债务/全部投入资本 (%)62.50663.45261.096--53.641
股东权益/带息债务 (%)57.14455.09559.83665.69181.314
股东权益/负债合计 (%)43.87640.89245.41652.54650.003
利息保障倍数 (X)3.3063.5333.6763.6323.968

营运能力分析
应收账款周转天数 (天)231.845165.206136.5200.000132.639
存货周转天数 (天)82.96474.27673.9180.00081.490